1628: The Genetics of Hypertrophic Osteodystrophy in the Weimaraner

Grant Status: Closed

Grant Amount: $10,000
John Angles, BVSc; University of California, Davis
October 26, 1998 - October 25, 1999


Breed(s): German Shepherd Dog, Weimaraner
Research Program Area: Musculoskeletal Conditions and Disease
Donate to Support this Research Program Area

Project Summary

This study�s data indicate that Hypertrophic Osteodystrophy (HOD) in the Weimaraner is an autosomal recessive disease (affected pups receive a copy of the mutated gene from each parent). The researchers collected DNA samples from extended families, which should provide the groundwork for the discovery of a marker that will allow for HOD carrier detection and the eventual elimination of this disease from the breed. HOD is a common disease in rapidly growing, large and giant purebred dogs. The Weimaraner has an unusual form of the disease typically seen between 8 to 16 weeks of age, with severe systemic manifestations, including fever and multiple body organ inflammation. Unlike most breeds, these dogs often require treatment with prednisone to prevent death. Using survey data, the researchers in this study noted a strong association between HOD and recent vaccination, with over 70 percent of affected Weimaraners vaccinated in the preceding 3 to 5 days.


None at this time.

Help Future Generations of Dogs

Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.

Learn How to Help

Connect With Us:
Get Canine Health News:
Please leave this field empty
American Kennel Club Canine Health Foundation, Inc

8051 Arco Corporate Dr.
Suite 300
Raleigh, NC 27617

Tax ID# 13-3813813

   2020 GuideStar logo

© 2020 AKC Canine Health Foundation | Privacy Policy | Site Map

Site by Blackbaud, Inc.

Powered by Blackbaud
nonprofit software